Breaking News

CHA Medical & Bio Group Breaks Ground

New Cell Gene Biobank facility backed by $250 million investment and comprises more than 700,000 square feet.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CHA Medical & Bio Group started construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea. Investing over $250 million in the project, the new 710,000 square foot site will comprise one of the world’s largest single facilities for cell and gene therapy manufacturing and advanced stem cell biobanking. The construction of the state-of-art facility is expected to be completed by the end of 2024. Within the facility, the space dedicated for cell and gene therapy will offer i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters